Rare deleterious mutations in Bruton’s tyrosine kinase as biomarkers for ibrutinib-based therapy: an in silico insight-Reference-Cited by-同舟云学术

Rare deleterious mutations in Bruton’s tyrosine kinase as biomarkers for ibrutinib-based therapy: an in silico insight

Published:2023-03-29 Issue:4 Volume:29 Page:
ISSN:1610-2940
Container-title:Journal of Molecular Modeling
language:en
Short-container-title:J Mol Model

Author:

Meena Jaishree,Hasija Yasha

Publisher

Springer Science and Business Media LLC

Subject

Computational Theory and Mathematics,Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Catalysis

Link

https://link.springer.com/content/pdf/10.1007/s00894-023-05515-6.pdf

Reference53 articles.

1. Fania L et al (2021) Cutaneous squamous cell carcinoma: From pathophysiology to novel therapeutic approaches. Biomedicines 9(2):1–33. https://doi.org/10.3390/BIOMEDICINES9020171

2. Stratigos A, Garbe C, Lebbe C, … J. M.-E. Journal of, and undefined 2015, ‘Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline’, Elsevier, Accessed: Jul. 29, 2022. [Online]. Available: https://sci-hub.do/https://www.sciencedirect.com/science/article/pii/S0959804915006255

3. Geidel G, Heidrich I, Kött J, Schneider SW, Pantel K, Gebhardt C (2022) Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma. Npj Precision Oncology 6(1):1–8. https://doi.org/10.1038/s41698-022-00261-z

4. Watson M, Holman DM, Maguire-Eisen M (2016) Ultraviolet radiation exposure and its impact on skin cancer risk. Semin Oncol Nurs. 32(3):241. https://doi.org/10.1016/J.SONCN.2016.05.005

5. Li S et al. (2021) Molecular subtypes of oral squamous cell carcinoma based on immunosuppression genes using a deep learning approach. Front Cell Dev Biol. 9:687245. https://doi.org/10.3389/FCELL.2021.687245/FULL